FDA approves first AI-driven diagnostic for general use by Q3 2026

The summit highlighted AI's growing role in healthcare diagnostics, with multiple companies showcasing early-stage products. Given the FDA's accelerated approval pathways for AI tools, the first general-use AI diagnostic is likely to receive approval within the next 12 months. Regulatory precedent from prior AI approvals (e.g., for stroke detection) supports this timeline.

Implied probability (Yes)

72%